Molecular Diagnostics
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
420
NCT01817192
Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)
Phase: N/A
Role: Lead Sponsor
Start: Sep 11, 2020
Completion: May 15, 2027
Loading map...